ACADIA PHARMACEUTICALS INC Annual Amortization of Intangible Assets in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2014 to 2023.
  • Acadia Pharmaceuticals Inc Amortization of Intangible Assets for the quarter ending March 31, 2024 was $5.29M.
  • Acadia Pharmaceuticals Inc annual Amortization of Intangible Assets for 2023 was $4.09M.
  • Acadia Pharmaceuticals Inc annual Amortization of Intangible Assets for 2022 was $0.000, a 100% decline from 2021.
  • Acadia Pharmaceuticals Inc annual Amortization of Intangible Assets for 2021 was $1.11M, a 25% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.09M +$4.09M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $0 -$1.11M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $1.11M -$369K -25% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $1.48M $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $1.48M +$1K +0.07% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $1.48M -$1K -0.07% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $1.48M +$492K +49.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $985K +$985K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.